New technologies in molecular genetics. the impact on epilepsy research

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 253-278

  Helbig, Ingo ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

15q13.3 microdeletion; Copy number variation; Epilepsy; Exome; Genome sequencing; Genomics; SCN1A; Seizures

Indexed keywords

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EPILEPSY; EXOME; FAMILY STUDY; GENE DELETION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN GENETICS; HUMAN GENOME; MOLECULAR GENETICS; PANEL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETIC PREDISPOSITION; GENETICS; MOLECULAR BIOLOGY; PROCEDURES; TRENDS;

ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR BIOLOGY;

EID: 84926376618     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00013-2     Document Type: Chapter

References (69)

1. Barcia G., Fleming M.R., Deligniere A., Gazula V.R., Brown M.R., Langouet M., Chen H., Kronengold J., Abhyankar A., Cilio R., Nitschke P., Kaminska A., Boddaert N., Casanova J.L., Desguerre I., Munnich A., Dulac O., Kaczmarek L.K., Colleaux L., Nabbout R. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat. Genet. 2012, 44(11):1255-1259.
2. Bar-Peled L., Chantranupong L., Cherniack A.D., Chen W.W., Ottina K.A., Grabiner B.C., Spear E.D., Carter S.L., Meyerson M., Sabatini D.M. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340(6136):1100-1106.
3. Caliebe A., Kroes H.Y., van der Smagt J.J., Martin-Subero J.I., Tonnies H., van 't Slot R.A., Nievelstein R., Muhle H., Stephani U., Alfke K., Stefanova I., Hellenbroich Y., Gillessen-Kaesbach G., Hochstenbach R., Siebert R., Poot M. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440Mb deletion in region 1q44 containing the HNRPU gene. Eur. J. Med. Genet. 2010, 53(4):179-185.
4. Campbell I.M., Rao M., Arredondo S.D., Lalani S.R., Xia Z., Kang S.H., Bi W., Breman A.M., Smith J.L., Bacino C.A., Beaudet A.L., Patel A., Cheung S.W., Lupski J.R., Stankiewicz P., Ramocki M.B., Shaw C.A. Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. PLoS Genet. 2013, 9(9):e1003797.
5. Campeau P.M., Kasperaviciute D., Lu J.T., Burrage L.C., Kim C., Hori M., Powell B.R., Stewart F., Felix T.M., van den Ende J., Wisniewska M., Kayserili H., Rump P., Nampoothiri S., Aftimos S., Mey A., Nair L.D., Begleiter M.L., De Bie I., Meenakshi G., Murray M.L., Repetto G.M., Golabi M., Blair E., Male A., Giuliano F., Kariminejad A., Newman W.G., Bhaskar S.S., Dickerson J.E., Kerr B., Banka S., Giltay J.C., Wieczorek D., Tostevin A., Wiszniewska J., Cheung S.W., Hennekam R.C., Gibbs R.A., Lee B.H., Sisodiya S.M. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014, 13(1):44-58.
6. Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J., Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S., Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S., Mackay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z., Zelnick N., Lerman-Sagie T., Lev D., Moller R.S., Gill D., Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F., Scheffer I.E., Mefford H.C. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 2013, 45(7):825-830.
7. Chen P., Lin J.J., Lu C.S., Ong C.T., Hsieh P.F., Yang C.C., Tai C.T., Wu S.L., Lu C.H., Hsu Y.C., Yu H.Y., Ro L.S., Lu C.T., Chu C.C., Tsai J.J., Su Y.H., Lan S.H., Sung S.F., Lin S.Y., Chuang H.P., Huang L.C., Chen Y.J., Tsai P.J., Liao H.T., Lin Y.H., Chen C.H., Chung W.H., Hung S.I., Wu J.Y., Chang C.F., Chen L., Chen Y.T., Shen C.Y., Taiwan S.J.S.C. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Engl. J. Med. 2011, 364(12):1126-1133.
8. Chen W.J., Lin Y., Xiong Z.Q., Wei W., Ni W., Tan G.H., Guo S.L., He J., Chen Y.F., Zhang Q.J., Li H.F., Lin Y., Murong S.X., Xu J., Wang N., Wu Z.Y. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat. Genet. 2011, 43(12):1252-1255.
9. Cherepanova N.S., Leslie E., Ferguson P.J., Bamshad M.J., Bassuk A.G. Presence of epilepsy-associated variants in large exome databases. J. Neurogenet. 2013, 27(1-2):1-4.
10. Conrad D.F., Keebler J.E., DePristo M.A., Lindsay S.J., Zhang Y., Casals F., Idaghdour Y., Hartl C.L., Torroja C., Garimella K.V., Zilversmit M., Cartwright R., Rouleau G.A., Daly M., Stone E.A., Hurles M.E., Awadalla P., Genomes P. Variation in genome-wide mutation rates within and between human families. Nat. Genet. 2011, 43(7):712-714.
11. Conti V., Carabalona A., Pallesi-Pocachard E., Parrini E., Leventer R.J., Buhler E., McGillivray G., Michel F.J., Striano P., Mei D., Watrin F., Lise S., Pagnamenta A.T., Taylor J.C., Kini U., Clayton-Smith J., Novara F., Zuffardi O., Dobyns W.B., Scheffer I.E., Robertson S.P., Berkovic S.F., Represa A., Keays D.A., Cardoso C., Guerrini R. Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene. Brain 2013, 136(Pt. 11):3378-3394.
12. Cooper G.M., Coe B.P., Girirajan S., Rosenfeld J.A., Vu T.H., Baker C., Williams C., Stalker H., Hamid R., Hannig V., Abdel-Hamid H., Bader P., McCracken E., Niyazov D., Leppig K., Thiese H., Hummel M., Alexander N., Gorski J., Kussmann J., Shashi V., Johnson K., Rehder C., Ballif B.C., Shaffer L.G., Eichler E.E. A copy number variation morbidity map of developmental delay. Nat. Genet. 2011, 43(9):838-846.
13. Corbett M.A., Bahlo M., Jolly L., Afawi Z., Gardner A.E., Oliver K.L., Tan S., Coffey A., Mulley J.C., Dibbens L.M., Simri W., Shalata A., Kivity S., Jackson G.D., Berkovic S.F., Gecz J. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am. J. Hum. Genet. 2010, 87(3):371-375.
14. de Kovel C.G., Trucks H., Helbig I., Mefford H.C., Baker C., Leu C., Kluck C., Muhle H., von Spiczak S., Ostertag P., Obermeier T., Kleefuss-Lie A.A., Hallmann K., Steffens M., Gaus V., Klein K.M., Hamer H.M., Rosenow F., Brilstra E.H., Trenite D.K., Swinkels M.E., Weber Y.G., Unterberger I., Zimprich F., Urak L., Feucht M., Fuchs K., Moller R.S., Hjalgrim H., De Jonghe P., Suls A., Ruckert I.M., Wichmann H.E., Franke A., Schreiber S., Nurnberg P., Elger C.E., Lerche H., Stephani U., Koeleman B.P., Lindhout D., Eichler E.E., Sander T. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010, 133(Pt. 1):23-32.
15. de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G., Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G., Veltman J.A., Vissers L.E. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 2012, 367(20):1921-1929.
16. Dibbens L.M., Mullen S., Helbig I., Mefford H.C., Bayly M.A., Bellows S., Leu C., Trucks H., Obermeier T., Wittig M., Franke A., Caglayan H., Yapici Z., EPICURE Consortium, Sander T., Eichler E.E., Scheffer I.E., Mulley J.C., Berkovic S.F. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum. Mol. Genet. 2009, 18(19):3626-3631.
17. Dibbens L.M., de Vries B., Donatello S., Heron S.E., Hodgson B.L., Chintawar S., Crompton D.E., Hughes J.N., Bellows S.T., Klein K.M., Callenbach P.M., Corbett M.A., Gardner A.E., Kivity S., Iona X., Regan B.M., Weller C.M., Crimmins D., Guerrero-Lopez R., Mulley J.C., Dubeau F., Licchetta L., Bisulli F., Cossette P., Thomas P.Q., Gecz J., Serratosa J., Brouwer O.F., Andermann F., Andermann E., van den Maagdenberg A.M., Pandolfo M., Berkovic S.F., Scheffer I.E. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat. Genet. 2013, 45(5):546-551.
18. Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y., Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R., Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C., Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A., Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B., Alldredge B.K., Bautista J.F., Berkovic S.F., Boro A., Cascino G.D., Consalvo D., Ottman R., Petrovski S., Poduri A., Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B., Alldredge B.K., Bautista J.F., Berkovic S.F., Boro A., Cascino G.D., Consalvo D., Crumrine P., Devinsky O., Dlugos D., Epstein M.P., Fiol M., Fountain N.B., French J., Friedman D., Geller E.B., Glauser T., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S., Crumrine P., Devinsky O., Dlugos D., Epstein M.P., Fiol M., Fountain N.B., French J., Friedman D., Geller E.B., Glauser T., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S., Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R., Kuzniecky R., Lowenstein D.H., McGuire S.M., Motika P.V., Novotny E.J., Ottman R., Paolicchi J.M., Parent J.M., Park K., Poduri A., Scheffer I.E., Shellhaas R.A., Sherr E.H., Shih J.J., Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A., Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P., Weisenberg J.L., Widdess-Walsh P. De novo mutations in epileptic encephalopathies. Nature 2013, 501(7466):217-221.
19. EPICURE Consortium, EMINet Consortium, Steffens M., Leu C., Ruppert A.K., Zara F., Striano P., Robbiano A., Capovilla G., Tinuper P., Gambardella A., Bianchi A., La Neve A., Crichiutti G., de Kovel C.G., Kasteleijn-Nolst Trenite D., de Haan G.J., de Haan G.J., Lindhout D., Gaus V., Schmitz B., Janz D., Weber Y.G., Becker F., Lerche H., Steinhoff B.J., Kleefuss-Lie A.A., Kunz W.S., Surges R., Lindhout D., Gaus V., Schmitz B., Janz D., Weber Y.G., Becker F., Lerche H., Steinhoff B.J., Kleefuss-Lie A.A., Kunz W.S., Surges R., Elger C.E., Muhle H., von Spiczak S., Ostertag P., Helbig I., Stephani U., Moller R.S., Hjalgrim H., Dibbens L.M., Bellows S., Oliver K., Mullen S., Scheffer I.E., Ostertag P., Helbig I., Stephani U., Moller R.S., Hjalgrim H., Dibbens L.M., Bellows S., Oliver K., Mullen S., Scheffer I.E., Berkovic S.F., Everett K.V., Gardiner M.R., Marini C., Guerrini R., Lehesjoki A.E., Siren A., Guipponi M., Malafosse A., Thomas P., Marini C., Guerrini R., Lehesjoki A.E., Siren A., Guipponi M., Malafosse A., Thomas P., Nabbout R., Baulac S., Leguern E., Guerrero R., Serratosa J.M., Reif P.S., Rosenow F., Serratosa J.M., Reif P.S., Rosenow F., Morzinger M., Feucht M., Zimprich F., Kapser C., Schankin C.J., Suls A., Smets K., Suls A., Smets K., De Jonghe P., De Jonghe P., De Jonghe P., Jordanova A., Caglayan H., Yapici Z., Yalcin D.A., Baykan B., Bebek N., Ozbek U., Gieger C., Wichmann H.E., Balschun T., Ellinghaus D., Franke A., Meesters C., Becker T., Wienker T.F., Hempelmann A., Schulz H., Ruschendorf F., Becker T., Wienker T.F., Hempelmann A., Schulz H., Ruschendorf F., Leber M., Pauck S.M., Trucks H., Toliat M.R., Nurnberg P., Avanzini G., Koeleman B.P., Leber M., Pauck S.M., Trucks H., Toliat M.R., Nurnberg P., Avanzini G., Koeleman B.P., Sander T. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum. Mol. Genet. 2012, 21(24):5359-5372.
20. Falace A., Filipello F., La Padula V., Vanni N., Madia F., De Pietri Tonelli D., de Falco F.A., Striano P., Dagna Bricarelli F., Minetti C., Benfenati F., Fassio A., Zara F. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am. J. Hum. Genet. 2010, 87(3):365-370.
21. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506(7487):179-184.
22. Gandomi S.K., Farwell Gonzalez K.D., Parra M., Shahmirzadi L., Mancuso J., Pichurin P., Temme R., Dugan S., Zeng W., Tang S. Diagnostic exome sequencing identifies two novel IQSEC2 mutations associated with x-linked intellectual disability with seizures: implications for genetic counseling and clinical diagnosis. J. Genet. Couns. 2014, 23:289-298.
23. Guven A., Tolun A. TBC1D24 truncating mutation resulting in severe neurodegeneration. J. Med. Genet. 2013, 50(3):199-202.
24. Han K., Holder J.L., Schaaf C.P., Lu H., Chen H., Kang H., Tang J., Wu Z., Hao S., Cheung S.W., Yu P., Sun H., Breman A.M., Patel A., Lu H.C., Zoghbi H.Y. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 2013, 503(7474):72-77.
25. Heinzen E.L., Radtke R.A., Urban T.J., Cavalleri G.L., Depondt C., Need A.C., Walley N.M., Nicoletti P., Ge D., Catarino C.B., Duncan J.S., Kasperaviciute D., Tate S.K., Caboclo L.O., Sander J.W., Clayton L., Linney K.N., Shianna K.V., Gumbs C.E., Smith J., Cronin K.D., Maia J.M., Doherty C.P., Pandolfo M., Leppert D., Middleton L.T., Gibson R.A., Johnson M.R., Matthews P.M., Hosford D., Kalviainen R., Eriksson K., Kantanen A.M., Dorn T., Hansen J., Kramer G., Steinhoff B.J., Wieser H.G., Zumsteg D., Ortega M., Wood N.W., Huxley-Jones J., Mikati M., Gallentine W.B., Husain A.M., Buckley P.G., Stallings R.L., Podgoreanu M.V., Delanty N., Sisodiya S.M., Goldstein D.B. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am. J. Hum. Genet. 2010, 86(5):707-718.
26. Heinzen E.L., Depondt C., Cavalleri G.L., Ruzzo E.K., Walley N.M., Need A.C., Ge D., He M., Cirulli E.T., Zhao Q., Cronin K.D., Gumbs C.E., Campbell C.R., Hong L.K., Maia J.M., Shianna K.V., McCormack M., Radtke R.A., O'Conner G.D., Mikati M.A., Gallentine W.B., Husain A.M., Sinha S.R., Chinthapalli K., Puranam R.S., McNamara J.O., Ottman R., Sisodiya S.M., Delanty N., Goldstein D.B. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am. J. Hum. Genet. 2012, 91(2):293-302.
27. Helbig I., Scheffer I.E., Mulley J.C., Berkovic S.F. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol. 2008, 7(3):231-245.
28. Helbig I., Mefford H.C., Sharp A.J., Guipponi M., Fichera M., Franke A., Muhle H., de Kovel C., Baker C., von Spiczak S., Kron K.L., Steinich I., Kleefuss-Lie A.A., Leu C., Gaus V., Schmitz B., Klein K.M., Reif P.S., Rosenow F., Weber Y., Lerche H., Zimprich F., Urak L., Fuchs K., Feucht M., Genton P., Thomas P., Visscher F., de Haan G.J., Moller R.S., Hjalgrim H., Luciano D., Wittig M., Nothnagel M., Elger C.E., Nurnberg P., Romano C., Malafosse A., Koeleman B.P., Lindhout D., Stephani U., Schreiber S., Eichler E.E., Sander T. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet. 2009, 41(2):160-162.
29. Helbig I., Hodge S.E., Ottman R. Familial cosegregation of rare genetic variants with disease in complex disorders. Eur. J. Hum. Genet. 2013, 21(4):444-450.
30. Helbig I., Swinkels M.E., Aten E., Caliebe A., van 't Slot R., Boor R., von Spiczak S., Muhle H., Jahn J.A., van Binsbergen E., van Nieuwenhuizen O., Jansen F.E., Braun K.P., de Haan G.J., Tommerup N., Stephani U., Hjalgrim H., Poot M., Lindhout D., Brilstra E.H., Moller R.S., Koeleman B.P. Structural genomic variation in childhood epilepsies with complex phenotypes. Eur. J. Hum. Genet. 2014, 22:896-901.
31. Heron S.E., Grinton B.E., Kivity S., Afawi Z., Zuberi S.M., Hughes J.N., Pridmore C., Hodgson B.L., Iona X., Sadleir L.G., Pelekanos J., Herlenius E., Goldberg-Stern H., Bassan H., Haan E., Korczyn A.D., Gardner A.E., Corbett M.A., Gecz J., Thomas P.Q., Mulley J.C., Berkovic S.F., Scheffer I.E., Dibbens L.M. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am. J. Hum. Genet. 2012, 90(1):152-160.
32. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., Kendall J., Grabowska E., Ma B., Marks S., Rodgers L., Stepansky A., Troge J., Andrews P., Bekritsky M., Pradhan K., Ghiban E., Kramer M., Parla J., Demeter R., Fulton L.L., Fulton R.S., Magrini V.J., Ye K., Darnell J.C., Darnell R.B., Mardis E.R., Wilson R.K., Schatz M.C., McCombie W.R., Wigler M. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74(2):285-299.
33. Ishida S., Picard F., Rudolf G., Noe E., Achaz G., Thomas P., Genton P., Mundwiller E., Wolff M., Marescaux C., Miles R., Baulac M., Hirsch E., Leguern E., Baulac S. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat. Genet. 2013, 45(5):552-555.
34. Kasperaviciute D., Catarino C.B., Matarin M., Leu C., Novy J., Tostevin A., Leal B., Hessel E.V., Hallmann K., Hildebrand M.S., Dahl H.H., Ryten M., Trabzuni D., Ramasamy A., Alhusaini S., Doherty C.P., Dorn T., Hansen J., Kramer G., Steinhoff B.J., Zumsteg D., Duncan S., Kalviainen R.K., Eriksson K.J., Kantanen A.M., Pandolfo M., Gruber-Sedlmayr U., Schlachter K., Reinthaler E.M., Stogmann E., Zimprich F., Theatre E., Smith C., Smith C., O'Brien T.J., Meng Tan K., Petrovski S., Robbiano A., Paravidino R., Zara F., Striano P., Sperling M.R., Buono R.J., Hakonarson H., Chaves J., Costa P.P., Silva B.M., da Silva A.M., de Graan P.N., Koeleman B.P., Becker A., Schoch S., von Lehe M., Silva B.M., da Silva A.M., de Graan P.N., Koeleman B.P., Becker A., Schoch S., von Lehe M., Reif P.S., Rosenow F., Becker F., Weber Y., Lerche H., Rossler K., Buchfelder M., Hamer H.M., Kobow K., Coras R., Blumcke I., Scheffer I.E., Rossler K., Buchfelder M., Hamer H.M., Kobow K., Coras R., Blumcke I., Scheffer I.E., Berkovic S.F., Weale M.E., UK Brain Expression Consortium, Delanty N., Depondt C., Cavalleri G.L., Berkovic S.F., Weale M.E., UK Brain Expression Consortium, Delanty N., Depondt C., Cavalleri G.L., Kunz W.S., Sisodiya S.M. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain 2013, 136(Pt. 10):3140-3150.
35. Kodera H., Nakamura K., Osaka H., Maegaki Y., Haginoya K., Mizumoto S., Kato M., Okamoto N., Iai M., Kondo Y., Nishiyama K., Tsurusaki Y., Nakashima M., Miyake N., Hayasaka K., Sugahara K., Yuasa I., Wada Y., Matsumoto N., Saitsu H. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum. Mutat. 2013, 34(12):1708-1714.
36. Lal D., Lal D., Trucks H., Moller R.S., Hjalgrim H., Koeleman B.P., de Kovel C.G., Visscher F., Weber Y.G., Lerche H., Becker F., Schankin C.J., Neubauer B.A., Surges R., Kunz W.S., Zimprich F., Franke A., Illig T., Ried J.S., Leu C., Nurnberg P., Sander T., EMINet Consortium, EPICURE Consortium Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. Epilepsia 2013, 54(2):265-271.
37. Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C., Steiner I., Hansen J., Courage C., Gallati S., Burki S., Strozzi S., Simonetti B.G., Grunt S., Steinlin M., Alber M., Wolff M., Klopstock T., Prott E.C., Lorenz R., Spaich C., Rona S., Lakshminarasimhan M., Kroll J., Dorn T., Kramer G., Synofzik M., Becker F., Weber Y.G., Lerche H., Bohm D., Biskup S. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012, 53(8):1387-1398.
38. Lemke J.R., Lal D., Reinthaler E.M., Steiner I., Nothnagel M., Alber M., Geider K., Laube B., Schwake M., Finsterwalder K., Franke A., Schilhabel M., Jahn J.A., Muhle H., Boor R., Van Paesschen W., Caraballo R., Fejerman N., Weckhuysen S., De Jonghe P., Larsen J., Moller R.S., Hjalgrim H., Addis L., Tang S., Hughes E., Pal D.K., Veri K., Vaher U., Talvik T., Dimova P., Guerrero Lopez R., Serratosa J.M., Linnankivi T., Lehesjoki A.E., Ruf S., Wolff M., Buerki S., Wohlrab G., Kroell J., Datta A.N., Fiedler B., Kurlemann G., Kluger G., Hahn A., Haberlandt D.E., Kutzer C., Sperner J., Becker F., Weber Y.G., Feucht M., Steinbock H., Neophythou B., Ronen G.M., Gruber-Sedlmayr U., Geldner J., Harvey R.J., Hoffmann P., Herms S., Altmuller J., Toliat M.R., Thiele H., Nurnberg P., Wilhelm C., Stephani U., Helbig I., Lerche H., Zimprich F., Neubauer B.A., Biskup S., von Spiczak S. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat. Genet. 2013, 45(9):1067-1072.
39. Lemke J.R., Hendrickx R., Geider K., Laube B., Schwake M., Harvey R.J., James V.M., Pepler A., Steiner I., Hortnagel K., Neidhardt J., Ruf S., Wolff M., Bartholdi D., Caraballo R., Platzer K., Suls A., De Jonghe P., Biskup S., Weckhuysen S. GRIN2B mutations in west syndrome and intellectual disability with focal epilepsy. Ann. Neurol. 2014, 75(1):147-154.
40. Lesca G., Rudolf G., Bruneau N., Lozovaya N., Labalme A., Boutry-Kryza N., Salmi M., Tsintsadze T., Addis L., Motte J., Wright S., Tsintsadze V., Michel A., Doummar D., Lascelles K., Strug L., Waters P., de Bellescize J., Vrielynck P., de Saint Martin A., Ville D., Ryvlin P., Arzimanoglou A., Hirsch E., Vincent A., Pal D., Burnashev N., Sanlaville D., Szepetowski P. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat. Genet. 2013, 45(9):1061-1066.
41. Man C.B., Kwan P., Baum L., Yu E., Lau K.M., Cheng A.S., Ng M.H. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007, 48(5):1015-1018.
42. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
43. McCormack M., Alfirevic A., Bourgeois S., Farrell J.J., Kasperaviciute D., Carrington M., Sills G.J., Marson T., Jia X., de Bakker P.I., Chinthapalli K., Molokhia M., Johnson M.R., O'Connor G.D., Chaila E., Alhusaini S., Shianna K.V., Radtke R.A., Heinzen E.L., Walley N., Pandolfo M., Pichler W., Park B.K., Depondt C., Sisodiya S.M., Goldstein D.B., Deloukas P., Delanty N., Cavalleri G.L., Pirmohamed M. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N. Engl. J. Med. 2011, 364(12):1134-1143.
44. Mefford H.C., Eichler E.E. Duplication hotspots, rare genomic disorders, and common disease. Curr. Opin. Genet. Dev. 2009, 19(3):196-204.
45. Mefford H.C., Sharp A.J., Baker C., Itsara A., Jiang Z., Buysse K., Huang S., Maloney V.K., Crolla J.A., Baralle D., Collins A., Mercer C., Norga K., de Ravel T., Devriendt K., Bongers E.M., de Leeuw N., Reardon W., Gimelli S., Bena F., Hennekam R.C., Male A., Gaunt L., Clayton-Smith J., Simonic I., Park S.M., Mehta S.G., Nik-Zainal S., Woods C.G., Firth H.V., Parkin G., Fichera M., Reitano S., Lo Giudice M., Li K.E., Casuga I., Broomer A., Conrad B., Schwerzmann M., Raber L., Gallati S., Striano P., Coppola A., Tolmie J.L., Tobias E.S., Lilley C., Armengol L., Spysschaert Y., Verloo P., De Coene A., Goossens L., Mortier G., Speleman F., van Binsbergen E., Nelen M.R., Hochstenbach R., Poot M., Gallagher L., Gill M., McClellan J., King M.C., Regan R., Skinner C., Stevenson R.E., Antonarakis S.E., Chen C., Estivill X., Menten B., Gimelli G., Gribble S., Schwartz S., Sutcliffe J.S., Walsh T., Knight S.J., Sebat J., Romano C., Schwartz C.E., Veltman J.A., de Vries B.B., Vermeesch J.R., Barber J.C., Willatt L., Tassabehji M., Eichler E.E. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 2008, 359(16):1685-1699.
46. Mefford H.C., Muhle H., Ostertag P., von Spiczak S., Buysse K., Baker C., Franke A., Malafosse A., Genton P., Thomas P., Gurnett C.A., Schreiber S., Bassuk A.G., Guipponi M., Stephani U., Helbig I., Eichler E.E. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet. 2010, 6(5):e1000962.
47. Mefford H.C., Yendle S.C., Hsu C., Cook J., Geraghty E., McMahon J.M., Eeg-Olofsson O., Sadleir L.G., Gill D., Ben-Zeev B., Lerman-Sagie T., Mackay M., Freeman J.L., Andermann E., Pelakanos J.T., Andrews I., Wallace G., Eichler E.E., Berkovic S.F., Scheffer I.E. Rare copy number variants are an important cause of epileptic encephalopathies. Ann. Neurol. 2011, 70(6):974-985.
48. Milh M., Falace A., Villeneuve N., Vanni N., Cacciagli P., Assereto S., Nabbout R., Benfenati F., Zara F., Chabrol B., Villard L., Fassio A. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum. Mutat. 2013, 34(6):869-872.
49. Miller D.T., Adam M.P., Aradhya S., Biesecker L.G., Brothman A.R., Carter N.P., Church D.M., Crolla J.A., Eichler E.E., Epstein C.J., Faucett W.A., Feuk L., Friedman J.M., Hamosh A., Jackson L., Kaminsky E.B., Kok K., Krantz I.D., Kuhn R.M., Lee C., Ostell J.M., Rosenberg C., Scherer S.W., Spinner N.B., Stavropoulos D.J., Tepperberg J.H., Thorland E.C., Vermeesch J.R., Waggoner D.J., Watson M.S., Martin C.L., Ledbetter D.H. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 2010, 86(5):749-764.
50. Moller R.S., Weber Y.G., Weber Y.G., Klitten L.L., Trucks H., Muhle H., Kunz W.S., Mefford H.C., Franke A., Kautza M., Wolf P., Dennig D., Schreiber S., Ruckert I.M., Wichmann H.E., Ernst J.P., Schurmann C., Grabe H.J., Tommerup N., Stephani U., Lerche H., Hjalgrim H., Helbig I., Sander T., EPICURE Consortium Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia 2013, 54(2):256-264.
51. Nakamura K., Kodera H., Akita T., Shiina M., Kato M., Hoshino H., Terashima H., Osaka H., Nakamura S., Tohyama J., Kumada T., Furukawa T., Iwata S., Shiihara T., Kubota M., Miyatake S., Koshimizu E., Nishiyama K., Nakashima M., Tsurusaki Y., Miyake N., Hayasaka K., Ogata K., Fukuda A., Matsumoto N., Saitsu H. De Novo mutations in GNAO1, encoding a Galphao subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am. J. Hum. Genet. 2013, 93(3):496-505.
52. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., Polak P., Yoon S., Maguire J., Crawford E.L., Campbell N.G., Geller E.T., Valladares O., Schafer C., Liu H., Zhao T., Cai G., Lihm J., Dannenfelser R., Jabado O., Peralta Z., Nagaswamy U., Muzny D., Reid J.G., Newsham I., Wu Y., Lewis L., Han Y., Voight B.F., Lim E., Rossin E., Kirby A., Flannick J., Fromer M., Shakir K., Fennell T., Garimella K., Banks E., Poplin R., Gabriel S., DePristo M., Wimbish J.R., Boone B.E., Levy S.E., Betancur C., Sunyaev S., Boerwinkle E., Buxbaum J.D., Cook E.H., Devlin B., Gibbs R.A., Roeder K., Schellenberg G.D., Sutcliffe J.S., Levy S.E., Betancur C., Sunyaev S., Boerwinkle E., Buxbaum J.D., Cook E.H., Devlin B., Gibbs R.A., Roeder K., Schellenberg G.D., Sutcliffe J.S., Daly M.J. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485(7397):242-245.
53. Neubauer B.A., Fiedler B., Himmelein B., Kampfer F., Lassker U., Schwabe G., Spanier I., Tams D., Bretscher C., Moldenhauer K., Kurlemann G., Weise S., Tedroff K., Eeg-Olofsson O., Wadelius C., Stephani U. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998, 51(6):1608-1612.
54. Ogiwara I., Ito K., Sawaishi Y., Osaka H., Mazaki E., Inoue I., Montal M., Hashikawa T., Shike T., Fujiwara T., Inoue Y., Kaneda M., Yamakawa K. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology 2009, 73(13):1046-1053.
55. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B., Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E., Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485(7397):246-250.
56. Petrovski S., Wang Q., Heinzen E.L., Allen A.S., Goldstein D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013, 9(8):e1003709.
57. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E. Global variation in copy number in the human genome. Nature 2006, 444(7118):444-454.
58. Reutlinger C., Helbig I., Gawelczyk B., Subero J.I., Tonnies H., Muhle H., Finsterwalder K., Vermeer S., Pfundt R., Sperner J., Stefanova I., Gillessen-Kaesbach G., von Spiczak S., van Baalen A., Boor R., Siebert R., Stephani U., Caliebe A. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 2010, 51(9):1870-1873.
59. Saitsu H., Kato M., Mizuguchi T., Hamada K., Osaka H., Tohyama J., Uruno K., Kumada S., Nishiyama K., Nishimura A., Okada I., Yoshimura Y., Hirai S., Kumada T., Hayasaka K., Fukuda A., Ogata K., Matsumoto N. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat. Genet. 2008, 40(6):782-788.
60. Scheffer I.E., Phillips H.A., O'Brien C.E., Saling M.M., Wrennall J.A., Wallace R.H., Mulley J.C., Berkovic S.F. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann. Neurol. 1998, 44(6):890-899.
61. Sharp A.J. Emerging themes and new challenges in defining the role of structural variation in human disease. Hum. Mutat. 2009, 30(2):135-144.
62. Sharp A.J., Mefford H.C., Li K., Baker C., Skinner C., Stevenson R.E., Schroer R.J., Novara F., De Gregori M., Ciccone R., Broomer A., Casuga I., Wang Y., Xiao C., Barbacioru C., Gimelli G., Bernardina B.D., Torniero C., Giorda R., Regan R., Murday V., Mansour S., Fichera M., Castiglia L., Failla P., Ventura M., Jiang Z., Cooper G.M., Knight S.J., Romano C., Zuffardi O., Chen C., Schwartz C.E., Eichler E.E. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 2008, 40(3):322-328.
63. Speed D., Hoggart C., Petrovski S., Tachmazidou I., Coffey A., Jorgensen A., Eleftherohorinou H., De Iorio M., Todaro M., De T., Smith D., Smith P.E., Jackson M., Cooper P., Kellett M., Howell S., Newton M., Yerra R., Tan M., French C., Reuber M., Sills G.E., Chadwick D., Pirmohamed M., Bentley D., Scheffer I., Berkovic S., Balding D., Palotie A., Marson A., O'Brien T.J., Johnson M.R. A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. Hum. Mol. Genet. 2014, 23(1):247-258.
64. Steinlein O.K. Genetic disorders caused by mutated acetylcholine receptors. Life Sci. 2007, 80(24-25):2186-2190.
65. Steinlein O.K., Kaneko S., Hirose S. Nicotinic acetylcholine receptor mutations. Jasper's Basic Mechanisms of the Epilepsies 2012, U.S. National Center for Biotechnology Information, Bethesda, MD. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
66. Striano P., Lispi M.L., Gennaro E., Madia F., Traverso M., Bordo L., Aridon P., Martinelli Boneschi F., Barone B., Barone B., dalla Bernardina B., Bianchi A., Capovilla G., De Marco P., De Marco P., De Marco P., Dulac O., Gaggero R., Gambardella A., Gambardella A., Nabbout R., Prud'homme J.F., Day R., Vanadia F., Vecchi M., Veggiotti P., Vigevano F., Viri M., Minetti C., Zara F. Linkage analysis and disease models in benign familial infantile seizures: a study of 16 families. Epilepsia 2006, 47(6):1029-1034.
67. Suls A., Jaehn J.A., Kecskes A., Weber Y., Weckhuysen S., Craiu D.C., Siekierska A., Djemie T., Afrikanova T., Gormley P., von Spiczak S., Kluger G., Iliescu C.M., Talvik T., Talvik I., Meral C., Caglayan H.S., Giraldez B.G., Serratosa J., Lemke J.R., Hoffman-Zacharska D., Szczepanik E., Barisic N., Komarek V., Hjalgrim H., Moller R.S., Linnankivi T., Dimova P., Striano P., Zara F., Marini C., Guerrini R., Depienne C., Baulac S., Kuhlenbaumer G., Crawford A.D., Lehesjoki A.E., de Witte P.A., Palotie A., Lerche H., Esguerra C.V., De Jonghe P., Helbig I., EuroEPINOMICS RES Consortium De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am. J. Hum. Genet. 2013, 93(5):967-975.
68. Weckhuysen S., Mandelstam S., Suls A., Audenaert D., Deconinck T., Claes L.R., Deprez L., Smets K., Hristova D., Yordanova I., Jordanova A., Ceulemans B., Jansen A., Hasaerts D., Roelens F., Lagae L., Yendle S., Stanley T., Heron S.E., Mulley J.C., Berkovic S.F., Scheffer I.E., de Jonghe P. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann. Neurol. 2012, 71(1):15-25.
69. Wei C.Y., Lee M.T., Chen Y.T. Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Hum. Mol. Genet. 2012, 21(R1):R58-R65.